Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.



Figure 4 Event rates with enoxaparin with or without glycoprotein IIb/IIIa inhibitors in the NICE trials. MI = myocardial infarction; NICE = National Investigators Collaborating on Enoxaparin; TVUR = target vessel urgent revascularization. Kereiakes DJ, Grines C, Fry E. Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary intervention. J Invas Cardiol 2001;13:272–8. Printed with permission from HMP Communications, 2002. Reprinted with permission from the American College of Cardiology Foundation, J Am Coll Cardiol 2001;37 Suppl A:1A–648A; Abstract 1253–97.





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement